Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-057049

Director sold 148,884 shares at an average $0.87 ($128,993)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ENGLEMAN EDGAR Director 2023-11-29 Sale −22,674 $0.91 $20,543 1,929,628 I: show line 1 in the form
ENGLEMAN EDGAR Director 2023-11-30 Sale −108,145 $0.86 $92,799 1,821,483 I: show line 2 in the form
ENGLEMAN EDGAR Director 2023-11-29 Sale −3,131 $0.91 $2,837 266,456 I: show line 3 in the form
ENGLEMAN EDGAR Director 2023-11-30 Sale −14,934 $0.86 $12,815 251,522 I: show line 4 in the form
Open-market sales · 148,884 sh · avg $0.87 · $128,993
Loading xslF345X05/doc4.xml…